Ozempic® (Semaglutide) Injection — Once-Weekly Pre-Filled Pen

Price range: $189.00 through $359.00

Extra Features
  • Dermatologist Approved
  • Secure Payments
  • Satisfaction Guarantee
  • Worldwide Shipping
  • Money Back Guarantee
Type 2 diabetes + cardiovascular risk reduction · Subcutaneous injection
Ozempic® 0.25 mg Starter Pen — Your First Four Weeks on Semaglutide
Once-weekly subcutaneous injection · 4-week initiation dose.
Ozempic® 0.5 mg Once-Weekly Pen — Finding Your Therapeutic Rhythm
Once-weekly subcutaneous injection · First maintenance dose
Ozempic® 1 mg Once-Weekly Pen — Full Therapeutic Stride
Once-weekly subcutaneous injection · Standard maintenance dose
Ozempic® 2 mg Once-Weekly Pen — Maximum Dose, Maximum Impact
Once-weekly subcutaneous injection · Highest approved dose
Guaranteed Safe Checkout
SKU: N/A Categories: ,

A gentle on-ramp to GLP-1 therapy. This opening dose isn’t about dramatic results yet — it’s about preparing your body for the journey ahead with minimal side effects.

Ozempic® 0.25 mg semaglutide is the four-week introductory dose prescribed to allow the body to acclimate to GLP-1 receptor agonism before escalation. Administered once weekly via pre-filled subcutaneous pen, it establishes the foundation for therapeutic dose advancement in the management of type 2 diabetes.

The first true working dose. Blood sugar begins responding, appetite starts to shift — one injection per week doing meaningful clinical work.
Ozempic® 0.5 mg semaglutide is the initial maintenance dose for glycemic control in adults with type 2 diabetes. Delivered via once-weekly pre-filled pen, it provides consistent GLP-1 receptor activation to improve HbA1c levels and support body weight management alongside diet and exercise.
Clinically proven glycemic control and meaningful weight reduction — the dose most patients reach and maintain long-term, backed by the SUSTAIN trial program.
Ozempic® 1 mgsemaglutide is the standard full-dose maintenance injection for type 2 diabetes management. Administered once weekly via pre-filled pen, it delivers robust HbA1c reduction and has demonstrated significant cardiovascular risk reduction in adults with established cardiovascular disease in the SUSTAIN-6 trial.
2 mg
The highest Medically approved Ozempic® dose — for patients who need stronger glycemic control, still delivered with just one injection per week.
Ozempic® 2 mg semaglutide is the highest medically-approved dose, offering additional HbA1c lowering for adults with type 2 diabetes requiring intensified therapy. Delivered via a dedicated 2 mg pre-filled pen device, it is prescribed when lower doses have not achieved adequate glycemic targets.
Dosage

0.25mg, 0.5mg, 1mg, 2mg

Reviews

There are no reviews yet.

Be the first to review “Ozempic® (Semaglutide) Injection — Once-Weekly Pre-Filled Pen”

Your email address will not be published. Required fields are marked *